University Clinical Centre
Gdansk, 80-211, Poland
NCT Number: NCT03863899
Ilioinguinal and iliohypogastric (ILIH) nerve blocks are frequently performed for analgesia in inguinal surgery.
The investigators hypothesized that preoperative ultrasound-guided ilioinguinal and iliohypogastric (ILIH) nerve blocks will produce better intraoperative analgesia and less analgesic requirement postoperatively in comparison to commonly used preoperative local infiltration anaesthesia for patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI).
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Gdansk, 80-211, Poland
It is a prospective, randomized trial.
The patients will be randomized to one of the 2 groups:
Group 1 - NERVE BLOCK. Ultrasound-guided ILIH nerve block will be performed by attending anaesthesiologist.
Group 2 - LOCAL INFILTRATION. Local anaesthetic infiltration of the operative area will be performed by operator.
During surgery patients will receive low-dose propofol infusion in order to achieve conscious sedation level, when indicated.
An extra dose of local anaesthetic drug for infiltration of the surgical field or intravenous fentanyl or/and intravenous paracetamol will be given as rescue analgesics in patients reporting pain sensation.
The patients will be observed for 24 hours. The pain at rest will be assessed using numeric rating scale (NRS 0 -10; 0 = no pain: 10 = max pain imaginable).
On the first postoperative day intravenous analgesics will be given on demand (paracetamol 1 g iv (if NRS <5) and oxycodone 2,5 mg iv (if NRS > or = 5)).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
drug mixture: 10-15 ml 0.5% ropivacaine plus 5 ml 1% lidocaine plus 1 mg dexamethasone plus 50 ug adrenaline
Other names: Ultrasound-guided ilioinguinal iliohypogastric nerve block
15-20 ml of mixture of 0.5% bupivacaine and 1% lidocaine (1:1)
Other names: Local anesthesia infiltration
Insertion of an aortic valve prothesis through the aorta accessed through femoral artery
Other names: Transaortic valve implantation
Administration of any analgesics during the operation
Other names: AIA
Administration of any analgesics within first 24 hours after the operation
Other names: APA
Time frame: 24 hours
The numeric rating scale will be used to determine the intraoperative and postoperative pain intensity levels of the patients. Pain intensity is scored 0-10 (0=no pain, 10=the worst pain imaginable). The pain intensity will be measured at 5 time points intraoperatively (femoral artery cannulation, aortic valve system introduction, aortic valve system removal, vessel closure devices insertion and the end of the operation) and at 2 time intervals postoperatively (0-12 hours and 12-24 hours).
Time frame: 24 hours
Fentanyl and paracetamol consumption during the operation.
Time frame: 24 hours
Oxycodone and paracetamol consumption in first 24 hours after the operation
Time frame: 3 days
Categorical quantification: Yes / No
Time frame: 1 year
Sum of anesthetics and analgesics administered during operation and within first 24 hours after operation
Medical University of Gdansk
Other
Pain Control With Ultrasound-guided Ilioinguinal Iliohypogastric Nerve Block Compared With Local Anesthesia Infiltration in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI): a Prospective, Randomized Trial
Acronym: TF-TAVI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06762288
Agnosia, Analgesia
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02729519
Aortic Valve Disease, Aortic Valve Stenosis
Montpellier, France
View Trial DetailsNCT07605780
Aortic Valve Disease, Aortic Valve Stenosis
Brescia, BS, Italy
View Trial DetailsNCT06171802
Aortic Valve Disease, Aortic Valve Stenosis
Copenhagen, Denmark
View Trial Details